Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Omeprazole Sodium for Injection

Approval Number

国药准字H20123034

Company海南葫芦娃药业集团股份有限公司

Registration Date

September 7, 2020

Drug Information

Generic Name

注射用奥美拉唑钠

Dosage Form

注射剂

Strength

60mg(按C17H19N3O3S计)

Drug Type

化学药品

Registration Date

September 7, 2020

Company Information

Applicant Company

Company Name海南葫芦娃药业集团股份有限公司

Manufacturing Company

Company Name海南葫芦娃药业集团股份有限公司

Company Address

海南省海口市海口国家高新区药谷工业园二期药谷四路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用奥美拉唑钠 - NMPA 批准文号 | MedPath